EQT launches €11B bid for Qiagen, targeting diagnostics growth

Swedish private equity firm EQT has made an €11 billion takeover bid for Qiagen, a diagnostics company headquartered in Venlo, Netherlands. The bid reflects continued private equity appetite for healthcare assets with stable cash flows. Regulatory and shareholder approval remain uncertain, and the deal's completion could face antitrust scrutiny.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works